Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism
- 1 September 2001
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 171 (1) , 29-45
- https://doi.org/10.1006/exnr.2001.7732
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Macrophage Colony Stimulating Factor Down-Regulates MCSF-Receptor Expression and Entry of Progenitors into the Osteoclast LineageJournal of Bone and Mineral Research, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease BrainsJournal of Biological Chemistry, 1996
- Pathogenesis of HIV-1 Associated NeurodegenerationCritical Reviews™ in Neurobiology, 1996
- Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brainNeurochemistry International, 1995
- Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cellsBrain Research, 1993
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brainExperimental Neurology, 1990